Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-28

Clinical Trial Update: Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical ketamine mouthwash for analgesia in patients undergoing chemoradiation or radiotherapy for head and neck cancer; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ketamine mouthwash (ketamine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Mucositis, Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-09-28